Atlas Trials

Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

Clinical trial NCT00564187 · COMPLETED

Trial details

NCT number
NCT00564187
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypertension
Start date
2003-02-01
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.